These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17643356)

  • 1. Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.
    Shima N; Kamata H; Katagi M; Tsuchihashi H; Sakuma T; Nemoto N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):123-9. PubMed ID: 17643356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct determination of glucuronide and sulfate of p-hydroxymethamphetamine in methamphetamine users' urine.
    Shima N; Tsutsumi H; Kamata T; Nishikawa M; Katagi M; Miki A; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):64-70. PubMed ID: 16263342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats.
    Shima N; Katagi M; Kamata H; Zaitsu K; Kamata T; Nishikawa M; Miki A; Tsuchihashi H; Sakuma T; Nemoto N
    Xenobiotica; 2008 Mar; 38(3):314-24. PubMed ID: 18274959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.
    Pizarro N; Llebaria A; Cano S; Joglar J; Farré M; Segura J; de la Torre R
    Rapid Commun Mass Spectrom; 2003; 17(4):330-6. PubMed ID: 12569443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
    Pizarro N; Ortuño J; Farré M; Hernández-López C; Pujadas M; Llebaria A; Joglar J; Roset PN; Mas M; Segura J; Camí J; de la Torre R
    J Anal Toxicol; 2002 Apr; 26(3):157-65. PubMed ID: 11991532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.
    da Silva DG; de Pinho PG; Pontes H; Ferreira L; Branco P; Remião F; Carvalho F; Bastos ML; Carmo H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):815-22. PubMed ID: 20167546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases.
    Schwaninger AE; Meyer MR; Zapp J; Maurer HH
    Toxicol Lett; 2011 Apr; 202(2):120-8. PubMed ID: 21295122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.
    Abraham TT; Barnes AJ; Lowe RH; Kolbrich Spargo EA; Milman G; Pirnay SO; Gorelick DA; Goodwin RS; Huestis MA
    J Anal Toxicol; 2009 Oct; 33(8):439-46. PubMed ID: 19874650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of MDMA and its metabolites in urine by GC and GC/MS].
    Shen M; Yan W; Shen B; Xiang P; Huang Z; Liu W; Bo J
    Fa Yi Xue Za Zhi; 1998; 14(1):10-1, 24, 61. PubMed ID: 11360579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of human UDP-glucuronyltransferases on the formation of the methylenedioxymethamphetamine (ecstasy) phase II metabolites R- and S-3-methoxymethamphetamine 4-O-glucuronides.
    Schwaninger AE; Meyer MR; Zapp J; Maurer HH
    Drug Metab Dispos; 2009 Nov; 37(11):2212-20. PubMed ID: 19666989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate-depletion approach.
    Schwaninger AE; Meyer MR; Maurer HH
    Drug Metab Dispos; 2011 Nov; 39(11):1998-2002. PubMed ID: 21795466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.
    Schwaninger AE; Meyer MR; Huestis MA; Maurer HH
    J Mass Spectrom; 2011 Jul; 46(7):603-14. PubMed ID: 21656610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine.
    Pirnay SO; Abraham TT; Huestis MA
    Clin Chem; 2006 Sep; 52(9):1728-34. PubMed ID: 16858076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
    Helmlin HJ; Bracher K; Bourquin D; Vonlanthen D; Brenneisen R
    J Anal Toxicol; 1996 Oct; 20(6):432-40. PubMed ID: 8889680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in urine drug testing.
    Andersson M; Gustavsson E; Stephanson N; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):22-8. PubMed ID: 18088576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
    Pichini S; Pujadas M; Marchei E; Pellegrini M; Fiz J; Pacifici R; Zuccaro P; Farré M; de la Torre R
    J Pharm Biomed Anal; 2008 Jun; 47(2):335-42. PubMed ID: 18262381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma.
    Kolbrich EA; Lowe RH; Huestis MA
    Clin Chem; 2008 Feb; 54(2):379-87. PubMed ID: 18089653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.
    Schwaninger AE; Meyer MR; Barnes AJ; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA; Maurer HH
    Clin Chem; 2011 Dec; 57(12):1748-56. PubMed ID: 21980168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
    Maresová V; Chadt J; Prikryl L
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.